health and fitness
prev1 ........2 next

buzz  1  + buzz

Flu drug aimed at Ebola may also fight norovirus, study finds

a shared story    1 hour 1 minute ago
LONDON (Reuters) - An experimental Japanese flu drug that has hit the headlines because of its potential to fight Ebola may also work against norovirus, the winter vomiting bug, British researchers said on Tuesday. As with Ebola, the research is still at an early stage but...(more) 

buzz  1  + buzz

Ebola low among top U.S. worries, Americans warned about scams

a shared story    2 hours 1 minute ago
(Reuters) - A new poll on Tuesday showed Ebola ranks well behind the economy, jobs and other issues among America's top problems, while a law enforcement official warned about Ebola-related scams promising protection against the virus that has killed thousands in West Africa. Ebola debuted in...(more) 

buzz  1  + buzz

Petition calls on Roche to cut breast cancer drug price

a shared story    3 hours 1 minute ago
LONDON (Reuters) - A British-led petition signed by 29,000 people has demanded that Switzerland's Roche, the world's biggest maker of cancer medicines, cut the price of its expensive new breast cancer drug Kadcyla. The campaign shows the growing pressure on drug companies as a raft of...(more) 

buzz  1  + buzz

Omeros suspends mid-stage trial of Huntington's drug, shares fall

a shared story    4 hours 1 minute ago
(Reuters) - Omeros Corp said it suspended enrolment in a mid-stage study testing its experimental Huntington's drug as the company evaluates data from a concurrent trial in rats, sending its shares down 10 percent before the bell. A high dose of the drug, OMS824, in several...(more) 

Analysts see U.S. approval of Novo Nordisk's obesity drug by year-end

a shared story    6 hours 1 minute ago
COPENHAGEN (Reuters) - The U.S. Food and Drug Administration is likely to approve Novo Nordisk's new drug to treat obesity this year, analysts said after wide expectations of an FDA decision late on Monday were not met. Danish drugmaker Novo Nordisk applied for approval for liragludtide,...(more) 

buzz  1  + buzz

Ebola fear factor subsides in U.S. financial markets

a shared story    8 hours 1 minute ago
By Yasmeen Abutaleb NEW YORK (Reuters) - Investors should expect more calm to return to U.S. equity markets after some of the most volatile trading since 2012 as the 21-day incubation period for Ebola passes for many in Texas without new infections. The market's big losses...(more) 

buzz  1  + buzz

Why Creating a Not To-Do List Leads to Innovation

a shared story    9 hours 1 minute ago
One day, Warren was having a conversation with his pilot about his life goals. Warren then asked him to create a list of the top 25 things he wanted to achieve in the next few years. After jotting down his list, Warren asked the pilot to...(more) 

buzz  1  + buzz

Actavis, Sanofi among bidders for Omega Pharma: Bloomberg

a shared story    10 hours 1 minute ago
(Reuters) - Generic drugmaker Actavis Plc and France's Sanofi SA are among the suitors for privately held Omega Pharma NV , Bloomberg reported, citing people familiar with the matter. Other bidders for the Belgian consumer healthcare company include Perrigo Co and private German drugmaker Boehringer Ingelheim...(more) 

buzz  1  + buzz

U.S. Republicans look to gain election ground on Ebola

a shared story    11 hours 1 minute ago
By Nick Carey CHICAGO (Reuters) - Ebola has moved to the front of campaign issues before U.S. November elections, as fear and criticism of the government's response to cases of the virus in the United States opened a new line of Republican attacks against President Barack...(more) 

buzz  1  + buzz

Worst Ebola outbreak on record tests global response

a shared story    12 hours 1 minute ago
(Reuters) - Global health authorities are struggling to contain the world's worst Ebola epidemic since the disease was identified in 1976. The virus has killed more than 4,500 people. Here is a timeline of the outbreak: March 22: Guinea confirms a previously unidentified hemorrhagic fever, which...(more) 

buzz  1  + buzz

Study shows exit screening vital to halting global Ebola spread

a shared story    13 hours 1 minute ago
By Kate Kelland LONDON (Reuters) - Three Ebola-infected travelers a month would be expected to get on international flights from the West African countries suffering epidemics of the deadly virus if there were no effective exit screening, scientists said on Tuesday. The three countries, Guinea, Liberia...(more) 

buzz  1  + buzz

AbbVie says $55 billion acquisition of Shire officially dead

a shared story    14 hours 1 minute ago
(Reuters) - U.S. drugmaker AbbVie Inc said on Monday it has reached agreement with Shire Plc to officially call off its proposed $55 billion purchase of the Irish company, and will pay Shire a $1.64 billion breakup fee for walking away from the deal. AbbVie, which...(more) 

prev1 ........2 next

last hour day week month all

ambient news

general | tech | lifestyle